miR-27b-3p directly targets PPARG to regulate pancreatic cancer progression.
Saved in:
| Title: | miR-27b-3p directly targets PPARG to regulate pancreatic cancer progression. |
|---|---|
| Authors: | Zhu L; Department of Intervention Radiology, Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, China., Long C; Department of Pharmacy, Shanghai Baoshan Luodian Hospital, Shanghai, 201908, China., Tang Y; Department of Pharmacy, Shanghai Baoshan Luodian Hospital, Shanghai, 201908, China., Wu C; Department of Pharmacy, Shanghai Baoshan Luodian Hospital, Shanghai, 201908, China., Wei L; Department of Pharmacy, Shanghai Baoshan Luodian Hospital, Shanghai, 201908, China., Ye T; Department of General Surgery, Shanghai Baoshan Luodian Hospital, No. 121, Luoxi Road, Luodian Town, Baoshan District, Shanghai, 201908, China. taogupvo984@163.com., Chen J; Department of Pharmacy, Baoshan Brance, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 1058, Huanzhen North Road, Baoshan District, Shanghai, 200444, China. junchen1908@163.com. |
| Source: | Discover oncology [Discov Oncol] 2026 Feb 05; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
